Cationic Surfactant Liposomes For Enhanced Cellular Delivery Of Sirna

We have collected information about Cationic Surfactant Liposomes For Enhanced Cellular Delivery Of Sirna for you. Follow the links to find out details on Cationic Surfactant Liposomes For Enhanced Cellular Delivery Of Sirna.


Enhanced siRNA delivery using cationic liposomes with new ...

    https://www.sciencedirect.com/science/article/pii/S0378517310002218
    Physicochemical properties of cationic liposomes were investigated. A GFP siRNA was used as a model siRNA to test the efficiency of cationic liposome-mediated siRNA delivery. The liposomes could enhance delivery efficiency and decrease cytotoxicity at an optimized lipid composition.Author: Hyun-Ki Kim, Enkhzaya Davaa, Chang-Seon Myung, Jeong-Sook Park

Cationic surfactin liposomes for enhanced cellular ...

    https://www.researchgate.net/publication/279760183_Cationic_surfactin_liposomes_for_enhanced_cellular_delivery_of_siRNA
    When compared with surfactin-free liposomes, cationic surfactin liposomes showed enhanced cellular delivery of siRNA in Hela cells. More than 85% of the cells were positive for siRNA and following its delivery 14% of surfactin-containing liposomes.

Application of cationic liposomes for delivery of nucleic ...

    https://www.sciencedirect.com/science/article/pii/S181808761300010X
    A number of researchers have sought to enhance the cellular delivery and gene-silencing efficiencies of siRNA using cationic liposomes. For example, cationic liposomes composed of DC-6-14, DOPE, and cholesterol were formulated to deliver siRNAs specific for firefly luciferase [35] .Author: Gayong Shim, Mi-Gyeong Kim, Joo Yeon Park, Yu-Kyoung Oh

Cationic liposomes for co-delivery of paclitaxel and anti ...

    https://www.sciencedirect.com/science/article/pii/S1773224718307408
    With this background present study is designed to deliver combination of chemotherapeutic drug and anticancer siRNA through cationic liposomes (CLs) to achieve enhanced efficacy in breast cancer. Paclitaxel (PTX) is the first-line drug against breast and ovarian cancers [ 9 ].Author: Upendra Bulbake, Nagavendra Kommineni, Maria Bryszewska, Maksim Ionov, Wahid Khan

Novel cationic cholesterol derivative-based liposomes for ...

    https://www.sciencedirect.com/science/article/pii/S037851730700960X
    Therefore, in this study, we focused on development of new cationic lipid-based delivery systems of siRNA that can increase serum stability and transfection efficiency. Here, we report that a newly synthesized cholesterol-derivative might be useful for enhanced cellular delivery of siRNA via liposomes in a serum-stable manner. 2. Material and ...Author: Su-Eun Han, Hyungu Kang, Ga Yong Shim, Min Sung Suh, Sun Jae Kim, Jin-Seok Kim, Yu-Kyoung Oh

Enhanced Intrapulmonary Delivery of Anticancer siRNA for ...

    https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)30655-4
    Apr 01, 2013 · Here, we report a cationic nanolipoplex as a pulmonary cellular delivery system for small-interfering RNA (siRNA). Six nanoliposomes differing in cationic lipids were formulated and screened in vitro and in vivo for cellular delivery functions in lung cells/tissues. Although the six nanoliposomes showed similar siRNA delivery efficiency in vitro, they exhibited significant …Author: Gayong Shim, Hyun Woo Choi, Sangbin Lee, Junhyeok Choi, Yong Hee Yu, Da Eui Park, Yongseok Choi, Cha...

Searching for Cationic Surfactant Liposomes For Enhanced Cellular Delivery Of Sirna?

You can just click the links above. The data is collected for you.

Related Delivery Info